New genes for lung disease discovered

NIH-funded study unveils potential genetic links to lung disease risk — New genes for lung disease discovered, New genetics study by consortium led by universities of Leicester and Nottingham – Scientists have discovered five genetic variants that are associated with the health of the human lung. The research by an international consortium of 96 scientists from 63 centres in Europe and Australia sheds new light on the molecular basis of lung diseases.

Human Genome Sequencing decoded in India

CSIR completes first ever Human Genome Sequencing in India – The Council of Scientific and Industrial Research (CSIR) has achieved completion of first ever Human Genome Sequencing in India. Scientist of CSIR at the Institute of Genomics and Integrative Biology (IGIB), Delhi have sequenced the Human Genome of an anonymous healthy Indian citizen.

Nutrition affects aging, proteins decisive for healthy aging

How nutrition affects healthy aging — The correct combination of proteins is decisive for healthy aging, not reducing the calories in our diet. – A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing.

Balancing protein intake may be key to long life

Balancing protein intake, not cutting calories, may be key to long life – Getting the correct balance of proteins in our diet may be more important for healthy ageing than reducing calories, new research funded by the Wellcome Trust and Research into Ageing suggests.

Genome 10K – to sequence 10000 vertebrates

‘Genome 10K’ proposal aims to sequence 10,000 vertebrates – An international group of scientists is proposing to generate whole genome sequences for 10,000 vertebrate species using technology so new it hasn’t yet been invented.

Researchers decoded genetic evolution of a breast cancer tumour

Major breast cancer breakthrough announced at BC Cancer Agency — BC scientists first in world to decode genetic evolution of a breast cancer tumour. – Canadian researchers have decoded all of the three billion letters in the DNA sequence of a metastatic lobular breast cancer tumor, a type of breast cancer which accounts for about 10 per cent of all breast cancers.

4 new risk factors for prostate cancer – deCODE genetics

deCODE Discovers Four New Risk Factors for Prostate Cancer – deCODE genetics (Nasdaq:DCGN) announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.

XMRV virus may cause prostate cancer in people

Researchers find first evidence of virus in malignant prostate cells in prostate cancer — XMRV retrovirus is associated with more aggressive tumors of prostate gland. – XMRV (Xenotropic murine leukemia virus-related virus) — a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells.

Gene variant linked to effectiveness of plavix

University of Maryland researchers identify gene variant linked to effectiveness of plavix — First study to use genome-wide scanning approach to locate gene that affects response to popular anti-clotting medication. – Patients with a certain genetic variation and who received the antiplatelet drug clopidogrel — Plavix — had a decreased platelet response to treatment, revealed by researchers.

New biomarker predicts response to hepatitis C treatment

New Biomarker Predicts Response to Hepatitis C Treatment – Researchers at Duke University Medical Center have identified the first genetic marker that predicts response to hepatitis C treatments, and a single letter of DNA code appears to make a huge difference.

Low birth weight linked to diabetes gene CDKAL1

Diabetes gene raises odds of lower birth weight – Gene previously shown to be involved in the development of type 2 diabetes also predisposes children to having a lower birth weight, revealed by researchers.

Lupus drug Benlysta effective for SLE patients

Lupus Research Institute Highly Encouraged by Benlysta Trial Results — First Phase 3 Lupus Drug Trial in Decades to Show Effectiveness. – Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) announced that BENLYSTA (belimumab, formerly LymphoStat-B?) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE).

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia